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SYMPOSIUM ON THE BIDEN ADMINISTRATION AND THE INTERNATIONAL LEGAL
ORDER
HOW THE BIDEN ADMINISTRATION CAN REINVIGORATE GLOBAL HEALTH
SECURITY, INSTITUTIONS, AND GOVERNANCE
Lawrence O. Gostin*, Eric A. Friedman**, and Sarah Wetter***
Joseph R. Biden was elected President of the United States during a period of compound crises for global health
and security: the worst pandemic in a century, as well as steep reverses in progress toward reducing poverty,
hunger, and disease. The United States has been in full retreat from global health leadership, fraying relationships
with allies, weakening global institutions, and engaging in nationalist populism that threatens global cooperation to
address worldwide challenges. Yet these tragic circumstances are also fertile soil for deep structural reforms.
President Biden can both bolster the immediate responses to COVID-19 and its vast ramiﬁcations, and spearhead
lasting changes to create a healthier and safer world, from which the United States would richly beneﬁt.1 His immediate task will be to bring U.S. economic and scientiﬁc strength to the COVID-19 response in partnership with the
World Health Organization (WHO). The Biden administration should also assume ﬁnancial and strategic leadership in bolstering world efforts to achieve the Sustainable Development Goals (SDGs), including its singular
pledge to leave no one behind. Finally, President Biden should empower the WHO and lead on reforms to the
global health architecture to advance the right to health.
At a time when the United States is facing its own COVID-19 crisis, the agenda we propose for President Biden
is ambitious. And global health leadership will need to complement other, related actions to address pressing
global crises that have immense health consequences, like climate change and mass migration. Yet bold leadership
on global health will beneﬁt all people, including Americans. As COVID-19 devastatingly demonstrates,
Americans’ health security is inextricably tied to global health security. Healthier populations are more economically productive; better global health will mean larger markets for U.S. goods and services. U.S. global health
leadership will open doors for cooperation on global challenges that themselves threaten the United States,
from climate change and antimicrobial resistant organisms to cybersecurity. Such leadership should also help
the United States to gain allies for stopping the global advance of authoritarianism and the erosion of human rights.
While requiring new funds, the spending linked to our proposals would be minute compared to the overall federal
budget, much less the U.S. economy.
* Faculty Director, O’Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, D.C., United States; Founding
O’Neill Chair in Global Health Law, Georgetown University Law Center; Director, World Health Organization Collaborating Center on National & Global
Health Law.
** Global Health Justice Scholar, O’Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington D.C., United
States.
*** Law Fellow, O’Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, D.C., United States.
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Responding to COVID-19 with Science and Solidarity
The U.S. failure to control COVID-19 domestically has placed the entire world at greater risk, while lowering
conﬁdence in U.S. public health and technical expertise and capacities. President Biden should work with governors and tribal leaders to implement a sound national plan with ﬁnancial support for crucial public health interventions. Equitable and efﬁcient distribution of Food and Drug Administration approved vaccines will be most
critical. Leading the COVID-19 response with science, President Biden should support science-based public
messaging and guard scientiﬁc agencies against political interference.
President Biden can also begin to restore the United States as a leader in combatting global health crises by
building cooperation among countries around a global COVID-19 strategy led by the WHO. His promised
Global Health Emergency Board would bring together world leaders and scientiﬁc experts to coordinate health
and economic responses to COVID-19 and future public health emergencies of international concern, securing
the recovery of vulnerable communities worldwide now and helping to protect them in the future. This Board
should complement and work closely with the Global Preparedness Monitoring Board, which assesses threats
and advises policymakers on actions required to prepare and respond to health emergencies.2
Global Health Security for the Future
Global health security requires being able to better predict, avert, and respond to a future pandemic. Launched
in 2014 under U.S. leadership, the Global Health Security Agenda (GHSA) convenes partner countries, international organizations, NGOs, and private sector companies to build and independently evaluate national health
system capacities, thereby improving countries’ pandemic preparedness. The Biden administration should
convene GHSA partners to revitalize the GHSA and revisit its focus areas in light of lessons from
COVID-19. The GHSA is ripe for additional areas, including building community trust and cooperation,
along with equitable preparation for and responses to health security threats.
Rectifying the outgoing administration’s untimely decisions, the Biden administration should re-establish the
White House National Security Council Directorate for Global Health Security and Biodefense, which monitors
global health risks and coordinates the U.S. response. The administration should re-launch the PREDICT virus
identiﬁcation and tracking project, which seeks to identify newly emerging pathogens in geographic “hotspots”
among animals likely to carry zoonotic diseases and builds both local and global capacities to prevent and respond
to an outbreak.3 And by ensuring that the U.S. Strategic National Stockpile is fully stocked with critical medical
supplies, including PPE, the administration could prepare the United States for another health emergency while
ensuring a ready source of PPE for other countries and eliminating the need for the United States to seek once
again to buy up much of the world’s supplies.
Furthermore, the Biden administration should address antimicrobial resistance—a steadily growing threat that
kills at least 700,000 people a year.4 The administration should increase research and development investments in
antimicrobials, while backing congressional measures to incentivize companies to develop new antimicrobials and
ensure their careful stewardship. The administration should also enhance regulations to limit agricultural antibiotic
use and ensure proper medical use. These efforts would help to keep future outbreaks at bay and limit global
spread, protecting people everywhere.

2
3
4

See Our Work, GLOBAL PREPAREDNESS MONITORING BOARD.
Predict: Program Info, ECOHEALTH ALLIANCE.
Review on Antimicrobial Resistance, Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations (Dec. 2014).
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To accelerate access to scientiﬁc advances, the Biden administration could leverage U.S. research and development funding to support the Open Science movement and make scientiﬁc knowledge accessible to all, while implementing protections against the harmful spread of misinformation. Likewise, as COVID-19 has underscored the
need for accessible and affordable vaccines and therapeutics everywhere, the administration should break with its
predecessors by welcoming other countries’ liberal use of ﬂexibility under the Agreement on Trade-Related
Aspects of Intellectual Property Rights (TRIPS) and avoid TRIPS-plus (even stricter patent protections than
are required by TRIPS) in any trade agreements, thereby increasing the availability of medicines in lower-income
countries.
Addressing Vast Humanitarian Crises
President Biden will also confront the pandemic’s massive knock-on effects. The pandemic’s health services
disruption may lead to a total of nearly 1.5 million AIDS, tuberculosis, and malaria deaths this year alone,
along with substantial increases in maternal and child deaths. The World Food Programme warned that the
number of people facing acute hunger could nearly double to 270 million. According to the WHO and
UNICEF, disruptions in childhood vaccine campaigns have led to an “alarming decline” in the number of children
receiving life-saving vaccines globally. There is an urgent need for new funding and global leadership.
Financial support for an unfolding humanitarian crisis is essential. President Biden should muster support in
Congress to dedicate at least 2 percent of COVID-19 spending to global humanitarian assistance. Congress has
thus far appropriated only about US$2 billion to the global response (compared to US$5.4 billion during the West
African Ebola epidemic). A 2 percent target is modest, particularly given the paucity of appropriations thus far.
International development assistance has traditionally comprised approximately 3 percent of U.S. discretionary
spending.5 If future COVID-19 appropriations are not in the multi-trillion-dollar range, a higher proportion
should be devoted to global assistance.
President Biden can also take other steps to ensure public health and safety around the world, such as rescinding
the Mexico City policy, which blocks U.S. global health funding for any organization performing, facilitating, or
promoting abortion, and restoring funding to the UN Population Fund, which supports strategies to improve
reproductive and maternal health worldwide. He should pledge one-third (the statutory maximum) of the additional US$5 billion the Global Fund to Fight AIDS, TB and Malaria needs in 2021 for its COVID-19 response.
Further, the president should mobilize global partners to develop and implement a global funding and action strategy developed in concert with the United Nations, WHO, civil society, and governments to achieve the SDGs.
Further, a multi-year debt-service moratorium and extensive debt cancellation could increase funds that lowerincome countries can devote to mitigating COVID-19’s health impacts and achieving the SDGs. Likewise, the
Biden administration should support the International Monetary Fund in its effort to create additional Special
Drawing Rights, which are somewhat like international currency.6 The Trump administration had opposed this
initiative, as it would provide signiﬁcant ﬁnancial resources to Iran and China.
Looking beyond the pandemic, the Biden administration should increase funding to support the health of the
tens of millions of people who depend on the international community for their most basic needs, including
refugees, internally displaced persons, and others requiring humanitarian assistance. President Biden should
build on the tradition of U.S. leadership in humanitarian assistance by working with Congress to fund at
least 40 percent of UN and World Food Programme appeals throughout his presidency, using generous U.S.
contributions to leverage increased funding from other countries.
5
6

C. Eugene Emery Jr. & Amy Sherman, Marco Rubio Says Foreign Aid is Less Than 1 Percent of Federal Budget, POLITIFACT (Mar. 11, 2016).
Mark Plant, Making the IMF’s Special Drawing Rights Work for COVID-19 Economic Relief, CTR. GLOBAL DEV. (Mar. 6, 2020).
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Strengthening the World Health Organization and International Health Regulations
President Trump blamed China for the pandemic while placing the WHO in the center of a geopolitical conﬂict
between the world’s two superpowers. President Biden agreed to rescind the U.S. notice of withdrawal from the
WHO on his ﬁrst day as president7 and now has an opportunity to reconcile relations and reconstruct the U.S. role
as a global contributor and leader.
The WHO is indispensable, from its global coordination during public health emergencies and its authoritative
technical guidance and support to countries across health areas to its role in advocacy, norm-setting, and the global
health agenda. President Biden should empower the WHO through reforms to the 2005 International Health
Regulations (IHR). He can lead our allies toward global solidarity and propose doubling WHO mandatory assessments, which now cover less than a quarter of WHO’s budget, with most voluntary contributions earmarked. The
Biden administration should also encourage the WHO Secretariat to reassess its overall budget needs, with the
possibility of a signiﬁcant increase in its overall budget (US$5.8 billion for 2020–20218).
The Biden administration should also work with WHO and civil society organizations (CSOs) to identify and
implement strategies to make WHO open to more CSOs and thus better represent the perspectives and needs of
marginalized populations in WHO deliberations and decisions. Presently, fewer than 220 non-state actors are in
ofﬁcial relations with WHO, nearly all with global, and the rest regional, remits,9 leaving out grassroots, national,
and other small CSOs. By contrast, more than 4000 CSOs have consultative status with the UN Economic and
Social Council.10 Currently, WHO’s Executive Board must approve a non-state actor’s ofﬁcial relations status. To
ensure that decisions on organizations’ participation status in WHO governance are not politicized, an independent body should handle ofﬁcial registration and approval of CSOs.
COVID-19 has revealed the need for signiﬁcant IHR reforms to enable WHO and the world to obtain complete
and accurate information on outbreaks and improve accountability among nations. The Biden administration
could spearhead a reform process here as well. First, the provisions on WHO’s use of unofﬁcial sources could
be revised to better protect sources’ conﬁdentiality and require credible information to be made public quickly.
Presently, WHO is required to attempt to verify information from unofﬁcial sources with the state at issue and
offer to collaborate in assessing the threat. Only if the state fails to respond within twenty-four hours to the offer to
collaborate “may” WHO—it is not required—share the information with other states.11 Meanwhile, WHO may
keep the source conﬁdential only “when it is duly justiﬁed.”12 Second, following a model established by the
Chemical Weapons Convention, the IHR should require countries to permit WHO to investigate ofﬁcial reports
of disease outbreaks, with full access to health workers, scientists, authorities, and civil society. When a novel outbreak strikes, WHO must be able to verify state reports independently in real time. Third, the IHR should allow for
public monitoring and scrutiny of state decisions that fail to adhere to WHO recommendations for outbreak control. Such a public monitoring system could help identify and prevent countries’ use of outbreaks as a guise to
implement xenophobic, nationalistic policies, and also support developing countries that fear economic instability
from travel and trade restrictions. Finally, the IHR should clearly deﬁne states’ international assistance and cooperation responsibilities to ensure needed funding and technical support and expand its list of core public health
capacities for preventing, detecting, and responding to potential public health emergencies.
7
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WHO has led a vital COVID-19 vaccine initiative along with Gavi, the Vaccine Alliance, and the Coalition for
Epidemic Preparedness Innovations. The COVID-19 Vaccine Global Access Facility (COVAX) aims to ensure
that ninety-two low- and middle-income countries can access COVID-19 vaccines once available. By early
December 2020, COVAX had 190 country partners, including China, but the United States and Russia had failed
to join. The United States should join, and work with partners to ensure a minimum of US$5 billion for the
COVAX Advanced Market Commitment, a ﬁnancing mechanism that guarantees funding for qualifying vaccines
at agreed-to prices. Doing so will enable manufacturers to scale-up production of qualifying vaccines and ensure
ready availability to all COVAX countries.
Toward a Healthier, More Equitable World
Beyond reform to current international arrangements, the Biden administration should use this moment to catalyze new initiatives for more equitable governance for global health. The early phase of the COVID-19 pandemic
was marked by a scramble for PPE, vaccines, testing kits, and other medical resources, not only between U.S.
states, but also globally, leaving lower-income countries facing a global bidding war that they could not win.
Then came “vaccine nationalism,” with predominantly wealthy nations (and to a lesser degree middle-income
countries) signing separate agreements with vaccine manufacturers to hoard limited supplies. As of early
November 2020, high-income countries had agreements covering 3.4 billion doses, compared to approximately
1.7 billion doses for middle-income countries and none for low-income countries. COVAX had agreements
covering only 500 million of the 2 billion doses it requires by the end of 2021 simply to vaccinate 20 percent
of participating countries’ populations.
To address these problems, the Biden administration should propose creating a permanent facility for distributing PPE and other medical supplies and equipment, diagnostics, therapies, and vaccines during epidemics and
pandemics. A permanent global distribution mechanism should be based on universality, equity across and within
countries, and need. This mechanism could draw heavily on principles proposed by the People’s Vaccine
movement, including fair allocation globally and domestically; prioritizing health workers and other higher-risk
populations; affordable pricing; data and intellectual property sharing; and transparency and accountability in
decision-making, with civil society participation.13 The mechanism could also require participants to avoid any
separate agreements with developers or manufacturers that may impede equitable distribution globally.
Going further, COVID-19’s devastating global effects open the possibility of still deeper systemic transformations. The Biden administration should lead in creating a rights-based global health architecture, which would
enhance equity and accountability and elevate the voices and priorities of marginalized populations.14 At its foundation would be the Framework Convention on Global Health, a proposed treaty that, if adopted, would
strengthen implementation of the right to health and promote global health equity.15 It would include mechanisms
to advance principles of equality and non-discrimination, accountability, and inclusive participation, to advance the
right to health across governments and other entities as well as across sectors, and at local, national, and global
levels. In addition, a Right to Health Capacity Fund could support right-to-health advocacy, accountability, and
participation mechanisms, while the Framework Convention on Global Health could require state parties to participate in equitable distribution mechanisms. Beyond strengthening global health security, these measures would

THE PEOPLE’S VACCINE.
Lawrence O. Gostin & Eric A. Friedman, Imagining Global Health with Justice: Transformative Ideas for Health and Well-Being While Leaving No
One Behind, 107 GEO. L.J. 1535 (2020).
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contribute to equitable universal health coverage and address underlying determinants of health, like clean water
and nutritious food.
Conclusion
Following a time of unprecedented U.S. retreat from global solidarity and cooperation with countries that share
our democratic values, a global health action agenda that meets the immediate crises of COVID-19 and its lasting
ramiﬁcations could pave the way for global health with justice. Our proposed global agenda could not be a more
ﬁtting way for the United States to demonstrate its full return to the international community, powerfully signaling
to the people of the world, including those in the most precarious situations who are most in need of hope and a
helping hand, that the United States is on their side.

